Neurological Institute Journal Special Issue– Fall 2016 Vol 9 | Number 1
This continuing medical education (CME) program is provided by Case Western Reserve University School of Medicine and is intended for all physicians, particularly neurologists and neurological surgeons, family practice and internal medicine physicians, interested in the latest advances in the management of neurological disorders.
Upon completion of this educational activity, the participant should be able to:
- Identify the advantages of proton beam therapy for the treatment of chordomas and chondrosarcomas of the spine
- Evaluate the use of proton beam therapy for chordomas and chondrosarcomas of the skull base
- Describe the presentation and the staged resection of a multicompartmental meningioma
- Explain how stereotactic laser ablation may be employed for treatment of difficult-to-access tumors such as those in the thalamus
Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Case Western Reserve University School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: November 14, 2016
Expiration Date: November 13, 2019
The policy of the Case Western Reserve University School of Medicine CME Program requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the education activity) disclose to the activity participants all relevant financial relationships with commercial interests. Where disclosures have been made, conflicts of interest, real or apparent, must be resolved. Disclosure will be made to activity participants prior to the commencement of the activity. The School of Medicine also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.
To Obtain AMA PRA Category 1 Credits™
- Read the Journal.
- Reflect on the content.
- Successfully complete the post-test located at: UHhospitals.org/NIJournalFall2015.
- A grade of 100% is required for passage.
- Complete the evaluation.
- Print the certificate of credit for your records.
Your credits will be recorded by the Case Western Reserve University School of Medicine CME Program and made a part of your transcript. For more information, contact the CME program at firstname.lastname@example.org.
There is no fee for this program.
Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
Although every effort is made to ensure that this material is accurate and up-to-date, it is provided for the convenience of the user and should not be considered definitive.
Neither the authors nor Case Western Reserve University School of Medicine nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.
Learners are encouraged to confirm the information contained herein with other sources.
This information should not be construed as personal medical advice and is not intended to replace medical advice offered by physicians. Case Western Reserve University School of Medicine will not be liable for any direct, indirect, consequential, special, exemplary, or other damages arising here from.
© 2015 Case Western Reserve University